The efficacy of cytarabine treatment is monitored through regular blood tests, bone marrow biopsies, and imaging studies. Blood tests help in assessing the patient's hematologic response, while bone marrow biopsies provide detailed information on the reduction of leukemic cells. Imaging studies may be utilized to evaluate the involvement of other organs and tissues.
